A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia

Insomnia affects 4.4–4.8% of the world’s population, but because the effect of hypnotic drugs is limited and may cause harmful side-effects, scientists are turning their attention to developing drugs that act on the orexin system. Daridorexant, a selective dual-orexin receptor antagonist (DORA), has...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziemichód, Wojciech, Grabowska, Karolina, Kurowska, Antonina, Biała, Grażyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502995/
https://www.ncbi.nlm.nih.gov/pubmed/36144776
http://dx.doi.org/10.3390/molecules27186041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502995/
https://www.ncbi.nlm.nih.gov/pubmed/36144776
http://dx.doi.org/10.3390/molecules27186041

Ejemplares similares